A. Léon

1.2k total citations
34 papers, 874 citations indexed

About

A. Léon is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, A. Léon has authored 34 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 9 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in A. Léon's work include Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (5 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers). A. Léon is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (5 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers). A. Léon collaborates with scholars based in France, United States and United Kingdom. A. Léon's co-authors include Loı̈c Guillevin, B Jarrousse, A Bussel, François Lhote, F. Fauvelle, T Généreau, Pascal Cohen, Quentin Guéranger, Barbara Bertocci and Ahmad Faili and has published in prestigious journals such as Nature Immunology, Antimicrobial Agents and Chemotherapy and Journal of Immunological Methods.

In The Last Decade

A. Léon

33 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Léon France 14 354 345 230 207 118 34 874
Caroline Roozendaal Netherlands 17 261 0.7× 303 0.9× 342 1.5× 123 0.6× 96 0.8× 37 906
Guillaume Bussone France 16 247 0.7× 388 1.1× 135 0.6× 101 0.5× 73 0.6× 31 904
Sylvia W.A. Kamerling Netherlands 15 709 2.0× 172 0.5× 219 1.0× 231 1.1× 55 0.5× 41 1.1k
I. Koetter Germany 16 283 0.8× 146 0.4× 267 1.2× 276 1.3× 37 0.3× 28 844
Sophie Ohlsson Sweden 14 282 0.8× 427 1.2× 121 0.5× 210 1.0× 138 1.2× 30 752
E. Christiaan Hagen Netherlands 11 194 0.5× 533 1.5× 173 0.8× 81 0.4× 191 1.6× 12 652
Nozomi Iwanaga Japan 12 181 0.5× 143 0.4× 238 1.0× 158 0.8× 37 0.3× 47 611
P. A. Dyer United Kingdom 18 442 1.2× 86 0.2× 248 1.1× 215 1.0× 73 0.6× 50 1.1k
Daisuke Kashiwakuma Japan 13 499 1.4× 174 0.5× 215 0.9× 114 0.6× 50 0.4× 17 901
Fu-lin Tang China 15 385 1.1× 104 0.3× 423 1.8× 161 0.8× 38 0.3× 52 860

Countries citing papers authored by A. Léon

Since Specialization
Citations

This map shows the geographic impact of A. Léon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Léon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Léon more than expected).

Fields of papers citing papers by A. Léon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Léon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Léon. The network helps show where A. Léon may publish in the future.

Co-authorship network of co-authors of A. Léon

This figure shows the co-authorship network connecting the top 25 collaborators of A. Léon. A scholar is included among the top collaborators of A. Léon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Léon. A. Léon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rezze, Gisele Gargantini, et al.. (2012). Primary Cutaneous Melanoma Arising in Agminated Melanocytic Nevi: CDKN2A and CDK4 Mutation Screening. Acta Dermato Venereologica. 92(1). 98–99. 6 indexed citations
2.
Léon, A.. (2011). Beyond Barriers: Creating Storytimes for Families of Children with ASD. NSUWorks (Nova Southeastern University). 9(3). 12. 4 indexed citations
3.
Rouard, Hélène, A. Léon, Jeanine Marquet, et al.. (2003). A closed and single‐use system for monocyte enrichment: potential for dendritic cell generation for clinical applications. Transfusion. 43(4). 481–487. 23 indexed citations
4.
Faili, Ahmad, Saïd Aoufouchi, Quentin Guéranger, et al.. (2002). AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line. Nature Immunology. 3(9). 815–821. 150 indexed citations
5.
Rouard, Hélène, Jeanine Marquet, A. Léon, et al.. (2002). IL-12 Secreting Dendritic Cells are Required for Optimum Activation of Human Secondary Lymphoid Tissue T Cells. Journal of Immunotherapy. 25(4). 324–333. 13 indexed citations
6.
Cao, Hua, Véronique Vergé, Carole Baron, et al.. (2000). Cutting Edge Communication: In Vitro Generation of Dendritic Cells from Human Blood Monocytes in Experimental Conditions Compatible for In Vivo Cell Therapy. Journal of Hematotherapy & Stem Cell Research. 9(2). 183–194. 43 indexed citations
7.
Zou, Gang‐Ming, et al.. (2000). Fas‐Mediated Apoptosis of Mouse Embryo Stem Cells: Its Role During Embryonic Development. American Journal of Reproductive Immunology. 43(4). 240–248. 9 indexed citations
8.
Rouard, Hélène, A. Léon, Bernard Klonjkowski, et al.. (2000). Adenoviral transduction of human ‘clinical grade’ immature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity. Journal of Immunological Methods. 241(1-2). 69–81. 50 indexed citations
9.
Lortholary, Olivier, F. Fauvelle, Michel Tod, et al.. (1999). Pharmacokinetics of teicoplanin during plasma exchange. Clinical Microbiology and Infection. 5(4). 213–218. 13 indexed citations
12.
Andreu, G., et al.. (1994). Extracorporeal photochemotherapy: Evaluation of two techniques and use in connective tissue disorders. Transfusion Science. 15(4). 443–454. 54 indexed citations
13.
Fauvelle, F., Olivier Lortholary, Michel Tod, et al.. (1994). Pharmacokinetics of ceftriaxone during plasma exchange in polyarteritis nodosa patients. Antimicrobial Agents and Chemotherapy. 38(7). 1519–1522. 18 indexed citations
14.
Cohen, Patrice, L Guillevin, M. Gayraud, et al.. (1993). Successful treatment of HIV-related vasculitis with peripheral neuropathy with short-term steroids followed by the association of zidovudine and plasmapheresis. Transfusion Science. 14(4). 383–389. 4 indexed citations
15.
Fauvelle, F., A. Léon, Patrick Nicolas, et al.. (1992). Pharmacokinetics of vidarabine in the treatment of polyarteritis nodosa. Fundamental and Clinical Pharmacology. 6(1). 11–15. 9 indexed citations
16.
Guillevin, Loı̈c, O. Fain, François Lhote, et al.. (1992). Lack of Superiority of Steroids Plus Plasma Exchange to Steroids Alone in the Treatment of Polyarteritis Nodosa and Churg‐Strauss Syndrome. Arthritis & Rheumatism. 35(2). 208–215. 123 indexed citations
17.
Fauvelle, F., Patrick Nicolas, A. Léon, et al.. (1991). Diclofenac, paracetamol, and vidarabine removal during plasma exchange in polyarteritis nodosa patients. Biopharmaceutics & Drug Disposition. 12(6). 411–424. 14 indexed citations
18.
Fauvelle, F., A. Léon, Olivier Petitjean, & L. Guillevin. (1991). Zidovudine removal during plasma exchange. Journal of Clinical Apheresis. 6(3). 155–157. 2 indexed citations
20.
Guillevin, Loı̈c, A. Léon, Yifat Amir Levy, et al.. (1983). Treatment of Progressive Systemic Sclerosis with Plasma Exchange. Seven Cases. The International Journal of Artificial Organs. 6(6). 315–318. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026